nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS1—Serotonin Transporter Activity—SLC6A4—conduct disorder	0.0747	0.0989	CbGpPWpGaD
Doxorubicin—NOS1—Serotonin Transporter Activity—MAOA—conduct disorder	0.0562	0.0744	CbGpPWpGaD
Doxorubicin—CBR3—NRF2 pathway—SLC6A4—conduct disorder	0.0421	0.0557	CbGpPWpGaD
Doxorubicin—NQO1—Dopamine metabolism—COMT—conduct disorder	0.0356	0.0471	CbGpPWpGaD
Doxorubicin—NQO1—Dopamine metabolism—MAOA—conduct disorder	0.0353	0.0468	CbGpPWpGaD
Doxorubicin—NOS1—Monoamine Transport—SLC6A4—conduct disorder	0.0318	0.0421	CbGpPWpGaD
Doxorubicin—NQO1—Estrogen metabolism—COMT—conduct disorder	0.0274	0.0363	CbGpPWpGaD
Doxorubicin—ABCB8—brain—conduct disorder	0.0231	0.0944	CbGeAlD
Doxorubicin—CBR3—brain—conduct disorder	0.0222	0.0908	CbGeAlD
Doxorubicin—AKR1A1—Metapathway biotransformation—COMT—conduct disorder	0.0209	0.0277	CbGpPWpGaD
Doxorubicin—NQO1—Oxidative Stress—MAOA—conduct disorder	0.0181	0.024	CbGpPWpGaD
Doxorubicin—AKR1A1—brain—conduct disorder	0.0171	0.0701	CbGeAlD
Doxorubicin—XDH—Oxidative Stress—MAOA—conduct disorder	0.0162	0.0215	CbGpPWpGaD
Doxorubicin—NDUFS7—brain—conduct disorder	0.0156	0.0637	CbGeAlD
Doxorubicin—AURKA—brain—conduct disorder	0.0145	0.0592	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0137	0.0181	CbGpPWpGaD
Doxorubicin—CYP1B1—Estrogen metabolism—COMT—conduct disorder	0.0132	0.0174	CbGpPWpGaD
Doxorubicin—NOS1—brain—conduct disorder	0.013	0.0531	CbGeAlD
Doxorubicin—NDUFS2—brain—conduct disorder	0.0129	0.0528	CbGeAlD
Doxorubicin—NDUFS3—brain—conduct disorder	0.0128	0.0522	CbGeAlD
Doxorubicin—DHCR7—brain—conduct disorder	0.0121	0.0496	CbGeAlD
Doxorubicin—CBR1—NRF2 pathway—SLC6A4—conduct disorder	0.0116	0.0154	CbGpPWpGaD
Doxorubicin—YWHAG—brain—conduct disorder	0.0111	0.0455	CbGeAlD
Doxorubicin—RALBP1—brain—conduct disorder	0.01	0.0411	CbGeAlD
Doxorubicin—NOS3—brain—conduct disorder	0.00988	0.0404	CbGeAlD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00954	0.0126	CbGpPWpGaD
Doxorubicin—CBR1—brain—conduct disorder	0.00937	0.0383	CbGeAlD
Doxorubicin—NQO1—Amino acid and derivative metabolism—CGA—conduct disorder	0.0093	0.0123	CbGpPWpGaD
Doxorubicin—AKR1C3—brain—conduct disorder	0.00926	0.0379	CbGeAlD
Doxorubicin—NOS3—Signaling by VEGF—WASF1—conduct disorder	0.009	0.0119	CbGpPWpGaD
Doxorubicin—CYP1B1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00893	0.0118	CbGpPWpGaD
Doxorubicin—POR—brain—conduct disorder	0.00845	0.0346	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00845	0.0112	CbGpPWpGaD
Doxorubicin—NDUFS2—p73 transcription factor network—EP300—conduct disorder	0.00778	0.0103	CbGpPWpGaD
Doxorubicin—NQO1—brain—conduct disorder	0.00751	0.0307	CbGeAlD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00704	0.00932	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—SLC6A4—conduct disorder	0.00678	0.00898	CbGpPWpGaD
Doxorubicin—ABCC3—brain—conduct disorder	0.00674	0.0276	CbGeAlD
Doxorubicin—ABCC10—brain—conduct disorder	0.00671	0.0274	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0066	0.00874	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00657	0.00869	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0064	0.00848	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0056	0.00741	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00555	0.00735	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00555	0.00735	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00551	0.0073	CbGpPWpGaD
Doxorubicin—YWHAG—FoxO family signaling—EP300—conduct disorder	0.00542	0.00717	CbGpPWpGaD
Doxorubicin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—conduct disorder	0.00539	0.00713	CbGpPWpGaD
Doxorubicin—CYP1B1—brain—conduct disorder	0.00527	0.0216	CbGeAlD
Doxorubicin—NOS2—Circadian rythm related genes—DRD4—conduct disorder	0.00518	0.00686	CbGpPWpGaD
Doxorubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00501	0.00663	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00497	0.00657	CbGpPWpGaD
Doxorubicin—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—conduct disorder	0.00488	0.00646	CbGpPWpGaD
Doxorubicin—NOS2—ATF-2 transcription factor network—EP300—conduct disorder	0.00478	0.00632	CbGpPWpGaD
Doxorubicin—ABCC1—brain—conduct disorder	0.00474	0.0194	CbGeAlD
Doxorubicin—NOS2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00437	0.00578	CbGpPWpGaD
Doxorubicin—ABCC3—NRF2 pathway—SLC6A4—conduct disorder	0.0043	0.00569	CbGpPWpGaD
Doxorubicin—AKR1C3—Metapathway biotransformation—COMT—conduct disorder	0.00429	0.00568	CbGpPWpGaD
Doxorubicin—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00414	0.00548	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00405	0.00536	CbGpPWpGaD
Doxorubicin—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00405	0.00536	CbGpPWpGaD
Doxorubicin—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00399	0.00529	CbGpPWpGaD
Doxorubicin—ABCG2—brain—conduct disorder	0.00393	0.0161	CbGeAlD
Doxorubicin—NDUFS3—Metabolism—CGA—conduct disorder	0.00392	0.00519	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CGA—conduct disorder	0.00392	0.00519	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—SLC6A4—conduct disorder	0.00377	0.00499	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0037	0.0049	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CGA—conduct disorder	0.00369	0.00488	CbGpPWpGaD
Doxorubicin—AURKA—G2/M Transition—EP300—conduct disorder	0.00366	0.00485	CbGpPWpGaD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00366	0.00484	CbGpPWpGaD
Doxorubicin—CYP2B6—brain—conduct disorder	0.00362	0.0148	CbGeAlD
Doxorubicin—AURKA—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00361	0.00478	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—DRD4—conduct disorder	0.00354	0.00469	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00341	0.00451	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CGA—conduct disorder	0.00314	0.00415	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00309	0.00409	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—EP300—conduct disorder	0.00301	0.00399	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CGA—conduct disorder	0.00293	0.00387	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00291	0.00384	CbGpPWpGaD
Doxorubicin—YWHAG—G2/M Transition—EP300—conduct disorder	0.00278	0.00367	CbGpPWpGaD
Doxorubicin—YWHAG—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00274	0.00362	CbGpPWpGaD
Doxorubicin—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0027	0.00357	CbGpPWpGaD
Doxorubicin—CYP2D6—brain—conduct disorder	0.00269	0.011	CbGeAlD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00267	0.00353	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00267	0.00353	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00254	0.00336	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CGA—conduct disorder	0.00249	0.00329	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00243	0.00322	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00217	0.00287	CbGpPWpGaD
Doxorubicin—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00217	0.00287	CbGpPWpGaD
Doxorubicin—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00215	0.00285	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00214	0.00284	CbGpPWpGaD
Doxorubicin—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.00214	0.00283	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—WASF1—conduct disorder	0.00199	0.00264	CbGpPWpGaD
Doxorubicin—ABCB1—brain—conduct disorder	0.00194	0.00792	CbGeAlD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0019	0.00252	CbGpPWpGaD
Doxorubicin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00188	0.00248	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00184	0.00244	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00182	0.00241	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—EP300—conduct disorder	0.00179	0.00237	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—COMT—conduct disorder	0.00177	0.00234	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—COMT—conduct disorder	0.00177	0.00234	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—MAOA—conduct disorder	0.00176	0.00233	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—MAOA—conduct disorder	0.00176	0.00233	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00172	0.00228	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CGA—conduct disorder	0.00171	0.00226	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0017	0.00225	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—COMT—conduct disorder	0.00167	0.0022	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—MAOA—conduct disorder	0.00165	0.00219	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CGA—conduct disorder	0.00165	0.00218	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CGA—conduct disorder	0.00153	0.00203	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00149	0.00198	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00144	0.00191	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00143	0.0019	CbGpPWpGaD
Doxorubicin—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00142	0.00189	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—COMT—conduct disorder	0.00142	0.00187	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—MAOA—conduct disorder	0.00141	0.00186	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—DRD4—conduct disorder	0.00139	0.00184	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CGA—conduct disorder	0.00139	0.00184	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CGA—conduct disorder	0.00138	0.00182	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00136	0.0018	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—COMT—conduct disorder	0.00132	0.00175	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—MAOA—conduct disorder	0.00131	0.00174	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00128	0.00169	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00127	0.00168	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00123	0.00162	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—EP300—conduct disorder	0.00122	0.00162	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—EP300—conduct disorder	0.00117	0.00154	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CGA—conduct disorder	0.00116	0.00154	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—EP300—conduct disorder	0.00113	0.0015	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CGA—conduct disorder	0.00113	0.00149	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—WASF1—conduct disorder	0.0011	0.00146	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CGA—conduct disorder	0.00108	0.00143	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—EP300—conduct disorder	0.00104	0.00138	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—COMT—conduct disorder	0.001	0.00133	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000997	0.00132	CbGpPWpGaD
Doxorubicin—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00099	0.00131	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000983	0.0013	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—WASF1—conduct disorder	0.000933	0.00123	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HTR2A—conduct disorder	0.000909	0.0012	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—EP300—conduct disorder	0.000883	0.00117	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—EP300—conduct disorder	0.000856	0.00113	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CGA—conduct disorder	0.000848	0.00112	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CGA—conduct disorder	0.000821	0.00109	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000808	0.00107	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—EP300—conduct disorder	0.00079	0.00105	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DRD4—conduct disorder	0.000772	0.00102	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—COMT—conduct disorder	0.000771	0.00102	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MAOA—conduct disorder	0.000766	0.00101	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—EP300—conduct disorder	0.00076	0.00101	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—EP300—conduct disorder	0.00076	0.00101	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CGA—conduct disorder	0.000747	0.000988	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—COMT—conduct disorder	0.000744	0.000984	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MAOA—conduct disorder	0.000739	0.000978	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000716	0.000948	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—EP300—conduct disorder	0.000714	0.000945	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—COMT—conduct disorder	0.000691	0.000915	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MAOA—conduct disorder	0.000687	0.000909	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—EP300—conduct disorder	0.000665	0.00088	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000656	0.000869	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD4—conduct disorder	0.000652	0.000863	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000652	0.000863	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000647	0.000857	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—COMT—conduct disorder	0.000628	0.000832	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MAOA—conduct disorder	0.000624	0.000826	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—EP300—conduct disorder	0.000618	0.000818	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—EP300—conduct disorder	0.000607	0.000804	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—EP300—conduct disorder	0.000566	0.00075	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—EP300—conduct disorder	0.000552	0.000731	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EP300—conduct disorder	0.000549	0.000727	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CGA—conduct disorder	0.000547	0.000724	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—COMT—conduct disorder	0.00051	0.000675	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MAOA—conduct disorder	0.000506	0.00067	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR2A—conduct disorder	0.000503	0.000666	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000491	0.00065	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—COMT—conduct disorder	0.000489	0.000647	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MAOA—conduct disorder	0.000485	0.000642	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EP300—conduct disorder	0.000481	0.000637	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000471	0.000623	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2A—conduct disorder	0.000425	0.000563	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00042	0.000556	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EP300—conduct disorder	0.000414	0.000549	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CGA—conduct disorder	0.000404	0.000534	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—COMT—conduct disorder	0.000383	0.000507	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EP300—conduct disorder	0.000381	0.000504	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CGA—conduct disorder	0.00038	0.000503	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MAOA—conduct disorder	0.00038	0.000503	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—COMT—conduct disorder	0.00037	0.00049	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000369	0.000488	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MAOA—conduct disorder	0.000368	0.000487	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000357	0.000472	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—COMT—conduct disorder	0.000337	0.000446	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MAOA—conduct disorder	0.000335	0.000443	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—EP300—conduct disorder	0.000331	0.000438	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EP300—conduct disorder	0.000322	0.000426	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—EP300—conduct disorder	0.000319	0.000422	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—EP300—conduct disorder	0.000297	0.000392	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—EP300—conduct disorder	0.00027	0.000357	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EP300—conduct disorder	0.000267	0.000353	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CGA—conduct disorder	0.000249	0.000329	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—COMT—conduct disorder	0.000247	0.000327	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MAOA—conduct disorder	0.000245	0.000325	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EP300—conduct disorder	0.000225	0.000298	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—EP300—conduct disorder	0.000219	0.000289	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—EP300—conduct disorder	0.00021	0.000277	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EP300—conduct disorder	0.000196	0.00026	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—COMT—conduct disorder	0.000182	0.000241	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MAOA—conduct disorder	0.000181	0.000239	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—COMT—conduct disorder	0.000172	0.000227	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MAOA—conduct disorder	0.00017	0.000226	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—EP300—conduct disorder	0.000164	0.000217	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—EP300—conduct disorder	0.000159	0.00021	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—EP300—conduct disorder	0.000145	0.000191	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—COMT—conduct disorder	0.000112	0.000149	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MAOA—conduct disorder	0.000111	0.000148	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—EP300—conduct disorder	0.000106	0.00014	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—EP300—conduct disorder	7.81e-05	0.000103	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—EP300—conduct disorder	7.36e-05	9.74e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EP300—conduct disorder	4.81e-05	6.37e-05	CbGpPWpGaD
